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Abstract
Serotonin and its receptors (HTRs) play critical roles in brain development and in the regulation of cognition, mood, and
anxiety. HTRs are highly expressed in human prefrontal cortex and exert control over prefrontal excitability. The serotonin
system is a key treatment target for several psychiatric disorders; however, the effectiveness of these drugs varies according
to age. Despite strong evidence for developmental changes in prefrontal Htrs of rodents, the developmental regulation of
HTR expression in human prefrontal cortex has not been examined. Using postmortem human prefrontal brain tissue from
across postnatal life, we investigated the expression of key serotonin receptors with distinct inhibitory (HTR1A, HTR5A) and
excitatory (HTR2A, HTR2C, HTR4, HTR6) effects on cortical neurons, including two receptors which appear to be expressed to
a greater degree in inhibitory interneurons of cerebral cortex (HTR2C, HTR6). We found distinct developmental patterns of
expression for each of these six HTRs, with profound changes in expression occurring early in postnatal development and
also into adulthood. However, a collective look at these HTRs in terms of their likely neurophysiological effects and major
cellular localization leads to a model that suggests developmental changes in expression of these individual HTRs may not
perturb an overall balance between inhibitory and excitatory effects. Examining and understanding the healthy balance is
critical to appreciate how abnormal expression of an individual HTR may create a window of vulnerability for the emergence
of psychiatric illness.
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Introduction
In the adult, modulation of the prefrontal cortex by the
neuromodulator serotonin is critical for emotional regulation and
resilience to stress [1,2,3,4]. The prefrontal cortex is a late
maturing brain region [5,6,7,8,9] with an extensive interrelation-
ship with the serotonin system [10,11,12]. Although the seroto-
nergic innervation of the prefrontal cortex matures early in
primate postnatal brain development [13], its effects on the
developmental neurophysiology and growth of the human
prefrontal cortex are much less well understood. Medicines that
target the serotonin system are used to treat symptoms of anxiety
or depression but appear to be less effective during childhood and
have an increased risk of adverse effects when administered to
children as compared to adults [14,15]. In fact, recent work
suggests that exposure to serotonergic medicines in development
increases behaviours suggestive of greater anxiety and sensitivity to
stress [16,17].
Serotonin has been implicated as a trophic factor in brain
development [18,19,20,21], and its effects show significant
developmental changes [22,23]. It is thought that these develop-
mental changes in the functional and pharmacological effects of
serotonin are due to changes in the expression of individual
postsynaptic receptors [22,24]. In humans, developmental changes
in the expression of serotonin receptors (HTRs) would alter the
functional effects of serotonin and serotonergic medicines, yet
developmental changes in HTRs have not been systematically
examined in human prefrontal cortex.
Postsynaptic serotonin receptors control how the prefrontal
cortex responds to serotonin at baseline and to the increased
release of serotonin during stress [1]. The most well-studied
receptors, HTR1A and HTR2A, are highly expressed in excitatory
neurons of prefrontal cortex [25,26,27,28]. Under baseline
conditions, endogenous serotonin release triggers an Htr1A-
mediated inhibition of prefrontal cortex [11,29,30] with Htr2A-
mediated effects potentially recruited at higher levels of serotonin
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22799release [25,30]. Behaviourally, these two serotonin receptors in
adult prefrontal cortex appear to have opposite effects on anxiety
and mood, with high levels of the inhibitory HTR1 being
anxiolytic [31,32], the excitatory Htr2A being required for normal
anxiety levels [33] and higher HTR2A levels being associated with
mood disturbance [34,35]. Work in rodents suggests that there is a
striking developmental change in the functional balance of Htr1A
and Htr2A expression [22,23]; this relationship has not yet been
examined in the developing human prefrontal cortex.
Beyond the well-studied HTR1A and HTR2A, the serotonin
receptor family is large, consisting of 14 members in total. Little is
known about the human developmental trajectories of all the
serotonin receptors expressed in prefrontal cortex. In this work, we
examine HTR1A and HTR2A together with a selection of the other
receptors, including HTR2C, HTR4, HTR5A, and HTR6. The
excitatory Htr2C receptor appears to be more strongly expressed in
cortical interneurons [36,37,38] and plays a critical role within
prefrontal cortex in controlling impulsivity [39,40]. The inhibitory
Htr5A receptor is expressed in a significant portion of cortical
pyramidal neurons [41,42,43,44] and may influence anxiety levels
under stress [45]. The excitatory Htr4 and Htr6 are thought to be
expressed respectively in pyramidal neurons [22,46,47] and
interneurons [48,49] and are both important in cognition [50,51].
We examine the developmental changes in the expression of
these serotonin receptors in human prefrontal cortex from infancy
to adulthood. Since serotonin receptors comprise a large family
with diverse localization and functions, we have chosen six
receptors with a variety of expression patterns and neurophysio-
logical coupling. We have also made particular effort to relate
developmental changes in the HTRs expression to developmental
changes in inhibitory interneuron markers in order to determine if
changes in serotonin neurotransmission may be synchronized with
the maturation of interneuron subtypes. This human develop-
mental information is important in order to appreciate vulnerable
time periods in the postnatal prefrontal cortex and to gain insight
into potential mechanisms underlying changes in the effects of
serotonin and serotonergic medicines.
Materials and Methods
Human Postmortem Brain Samples
Human postmortem tissue from the dorsolateral prefrontal cortex
was obtained from the NICHD Brain and Tissue Bank for
Developmental Disorders at the University of Maryland, Balti-
more, MD, USA (contract HHSN275200900011C, Ref. No. N01-
HD-9-0011). Written consent was obtained from individuals or
their next of kin before tissue donation. Samples were obtained
from 59 individuals who ranged in age from six weeks to 49 years
and were grouped into seven developmental periods: neonates
(n=8), infants (n=13), toddlers (n=7), school age (n=7),
teenagers (n=7), young adults (n=9) and adults (n=8).
Demographic details and sample characteristics are summarised
in Table 1 with full details available in Table S1. Sample
preparation for mRNA expression analyses have been described
previously [52]. This study was carried out in accordance with the
latest version of the Declaration of Helsinki after specific approval
by the University of NSW Human Research Ethics Committee
(HREC # 07261).
Quantitative Real Time RT-PCR Analysis
HTR transcript expression levels were assessed using quantita-
tive real-time RT-PCR (qPCR). cDNA was synthesized from total
RNA (3 mg) of the entire cohort individuals using SuperScriptH
First-Strand Synthesis kit and random hexamers following the
manufacturer’s instructions (Invitrogen, Carlsbad, CA USA). The
transcript levels for six genes of interest and four housekeeper
genes were measured using an ABI Prism 7900HT Fast Real time
PCR system with a 384-well format and TaqMan Gene
Expression Assays (Applied Biosystems) (HTR1A: Hs002650
14_s1, HTR2A: Hs01033524_m1, HTR2C: Hs00168365_m1, HT
R4: Hs00168380_m1, HTR5A: Hs00225153_m1, HTR6: Hs0016
8381_m1, GUSB: Hs99999908_m1, HMBS: Hs00609297_m1,
PPIA: Hs99999904_m1 and UBC: Hs00824723_m1 ). Cycling
conditions and reaction amounts were as previously described
[53].
Gene Expression Normalization
In order to reduce the variability inherent in measuring mRNA
from this number of individuals the data was normalized through
the use of housekeeping genes. We chose four —b-glucuronidase
(GUSB), hydroxymethylbilanesynthase (HMBS), peptidylprolyli-
somerase A (PPIA), and ubiquitin C (UBC) — which did not
change through development (ANOVA, GUSB; F(6,61) =0.5 ,
p=0.8, HMBS; F(6,61) =0.5, p=0.7, PPIA; F(6,60) =0.4,
p=0.9, UBC; F(6,61) =0.08, p=0.7). The stability of the
expression of these genes was assessed through the use of the
geNorm program which calculates the average pair-wise variation
of a particular gene with all other control genes yielding an M-
Value with lower number indicating greater stability (GUSB:
0.871, HMBS: 0.811, PPIA: 0.876, UBC: 0.923) [54]. We have
avoided ribosomal mRNAs, which are expressed at very high
levels, and instead chose two high expression and two medium
Table 1. Demographics of developmental subjects in the Maryland Brain Bank postmortem tissue cohort.
Group Age (years) PMI (hours) Gender pH Race RIN
Neonate 0.17 (0.11–0.24) 22.566.0 5M : 3F 6.6060.14 6AA : 2C 8.0160.50
Infant 0.53 (0.25–0.91) 17.566.4 8M : 5F 6.6160.16 10AA : 3C 7.5660.92
Toddler 2.51 (1.58–4.64) 19.265.8 3M : 4F 6.7760.17 4AA : 3C 7.1560.72
School Age 9.98 (7.84–12.98) 14.465.2 3M : 4F 6.7060.21 2AA : 5C 7.5460.58
Teenage 16.8 (16.34–17.82) 17.963.9 5M : 2F 6.7460.08 1AA : 6C 6.9860.86
Young Adult 23.2 (20.14–25.38) 13.768.3 5M : 4F 6.6760.23 5AA : 4C 7.4660.97
Adult 43.4 (35.99–48.7) 13.464.6 5M : 3F 6.6060.27 4AA : 4C 7.1660.93
All Ages 13.0 (0.11–48.7) 16.966.4 34M : 25F 6.6660.19 32AA : 27C 7.4360.84
All values 6 standard deviation, PMI – post-mortem interval, RIN – RNA integrity number, AA - African American, C – Caucasian.
doi:10.1371/journal.pone.0022799.t001
Developmental Changes in Human Prefrontal HTRs
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varied biological processes of the cell following the criteria
previously established [54]. The housekeeping genes were
averaged through the use of a geometric mean which was then
used to normalize the HTR gene expression data.
Statistical Analysis
Population outliers were identified for each transcript measured
through qPCR using the Grubb’s test (p,0.05), resulting in the
removal of the following individuals: one toddler from HTR2C,
one young adult and one adult from HTR4, one young adult from
HTR5A, and two infants and an adult from HTR6. All data were
normally distributed (Lilliefors) and showed homogeneity of
variance (Levene’s, p.0.20). Statistical tests were performed using
PASW statistics (version 18 for MacOSX, SPSS, Chicago, Il,
USA) and included one-way analysis of variance (ANOVA) with a
post hoc Fisher LSD to determine significant changes in gene
expression between groups. Using normalized qPCR data,
Pearson correlations were performed between the genes of interest
and the brain sample characteristics (pH, RIN, PMI) with
significant correlations being co-varied in an Analysis of
Covariance (ANCOVA). For Figure 1b and to calculate the
relative balance between HTRs with excitatory and inhibitory
contributions, the measurements for HTR5A were multiplied by 10
to correct for the difference in cDNA dilution used in detection.
Only individuals who had qPCR measurements from all six HTRs
were included in the ANOVA to assess for changes in the
expression ratio of excitatory and inhibitory receptors (neo-
nate=8, infant=11, toddler=6, school age=7, teenage=7,
young adult=6, adult=6). Identifying significant linkages between
the mRNA expression of the HTRs expressed by interneurons and
other interneuron markers was done using a stepwise regression
analysis and the interneuron marker mRNA expression data from
Fung et al. [7]. This method allowed us to include only
Figure 1. Developmental pattern of expression of Gai-coupled serotonin receptors: HTR1A and HTR5A. (a) Normalized qPCR expression
for HTR1A in human prefrontal cortex across postnatal development. The expression of HTR1A does not significantly change across the
developmental groups (F(6,53) =0.6, p=0.8). (b) Normalized qPCR expression for HTR5A in human prefrontal cortex across postnatal development.
There is a significant developmental change in HTR5A expression (F(6,43)=2.9, p,0.02), Asterisks show the significance levels of an ANOVA post-hoc
Fisher LSD test (* p,0.05).
doi:10.1371/journal.pone.0022799.g001
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significantly associated with developmental changes in individual
HTR mRNA expression.
Results
To investigate developmental changes in the expression of a
subset of important serotonin receptors in human prefrontal cortex,
we performed qPCR on a large sample of postmortem brains from
infancy to adulthood. The HTRs we targeted include the two major
serotonin receptors expressed in the prefrontal cortex, HTR1A and
HTR2A,a sw e l la sHTR2C, HTR4, HTR5A, HTR6. As illustrated in
Table 2, these receptors include representatives of all three classes
of G-protein coupling (Gai,G aq,a n dG as), which have distinct
effects on cellular excitability. However, to appreciate the potential
netoveralleffectofeachreceptoronthe excitabilityoftheprefrontal
cortex, this receptor coupling must be viewed in the context of
cellular localization. As illustrated in Table 3, some HTRs are
predominantly expressed by excitatory pyramidal neurons whereas
others are mainly expressed in inhibitory interneurons. Lastly, we
looked at possible confounds to HTR mRNA expression levels arising
from our sample characteristics.
HTR1A and HTR5A: Gai-coupled receptors
Differences were observed with qPCR in the expression in one of
the two inhibitory serotonin receptors in prefrontal cortex, as
illustrated in Figure 1. We find that the mRNA for HTR1A does not
change significantly across the age range evaluated (F(6,53) =0.6,
p=0.8). This developmental pattern contrasts with that for HTR5A
mRNA expression which remains consistent across postnatal
development, but then climbs sharply in adulthood (ANOVA:
F(6,53) =2.9, p,0.02, Fisher LSD: p,0.02 adult vs. infant, neonate,
school age, young adult), as illustrated in Figure 1b.
HTR2A and HTR2C: Gaq-coupled receptors
There is strong developmental regulation of HTR2A mRNA in
the human prefrontal cortex (F(6,53) =5.3, p,0.001). As
illustrated in Figure 2a, this receptor shows a low level of
expression in infancy, increases during the infant years, plateaus in
the toddler to teenager period, and then declines to adult levels.
The similarly-coupled HTR2C appears to have opposing
behavioural effects to the HTR2A [39,40] potentially as a result
of different cellular expression [36,37,38,46], as illustrated in
Table 3. Here, we find that in human prefrontal cortex HTR2C
mRNA shows gradual developmental up-regulation (F(6,52) =4.7,
p=0.001). Figure 2b illustrates that prefrontal HTR2C expres-
sion reaches a highest expression during young adulthood.
HTR4 and HTR6: Gas-coupled receptors
HTR4 mRNA is expressed in prefrontal pyramidal neurons
[24,46,47] although this receptor results in weaker prefrontal
excitation than HTR2C [24]. Figure 3a indicates that prefrontal
HTR4 mRNA is developmentally regulated (F(6,50) =4.6,
p=0.001), with peak expression during the school age and teenage
years.
In contrast to the anatomical location of HTR4, HTR6 has been
previously suggested to have strong expression in inhibitory
interneurons [48,49]. Here, we find that there is a significant
developmental regulation (F(6,50)=4.9, p=0.001), With the
greatest HTR6 mRNA expression in the toddler age group and
a significant down-regulation after childhood (Figure 3b).
Relationship with inhibitory interneuron marker mRNA
Since HTR2C and HTR6 are thought to be more strongly
expressed in cortical interneurons, we examined whether their
expression was related to developmental changes in common
interneuron markers, such as parvalbumin (PV), calbindin (CB),
somatostatin (SST) and cholecystokinin (CCK). As hypothesized,
developmental changes in HTR2C and HTR6 mRNA were
significantly associated with individual interneuronal markers,
but these two HTRs appear related to distinct interneuron
markers. Developmental changes in HTR6 mRNA were signifi-
cantly matched with developmental changes in CB mRNA
(R=0.4, F(1,45)=9.4. p=0.004, b=0.4). By contrast, develop-
mental changes in HTR2C were significantly associated with
changes in CCK (R=0.6, F(1,47)=28.5. p,0.001, b=0.6).
Despite some expression in interneurons [28,55,56], the develop-
mental pattern of HTR1A expression could not be linked to any
interneuron marker through regression. However, developmental
changes in HTR2A mRNA were strongly associated with
developmental changes in PV mRNA and CB mRNA (R=0.9,
F(2,46)=98.2. p,0.001, b(PV)=0.7, b(CB)=0.5).
Correlations with postmortem sample characteristics
Cortical pH was correlated with the expression of several
serotonin receptors mRNAs (HTR2A: r=0.51, p,0.001, HTR2C:
r=0.36, p=0.007, HTR6: r=0.29, p=0.03, HTR4: r=0.36,
p=0.01). PMI showed a significant negative correlation with
HTR2C (r=-0.28, p=0.04). There was no correlation between
RIN values and any serotonin receptor. To establish if pH or PMI
significantly changed the effect of age group, we performed
ANCOVAs to compensate. When these correlated sample
characteristics were co-varied, the results of results for all the
HTR mRNAs remained statistically significant: HTR2A:
F(6,52)=3.7, p=0.004, HTR2C: F(6,50)=2.9, p=0.02, HTR6:
F(6,49)=3.9, p=0.003 HTR4: F(6,49)=3.7, p=0.004).
Demographic effects other than age
None of the mRNAs encoding serotonin receptors varied
significantly with gender. Caucasians did have a significantly
increased expression of HTR2A mRNA compared to African
Table 2. The electrophysiological effects of the analyzed postsynaptic serotonin receptors (HTRs).
Receptor subtype G-protein Ion channel mediator Physiological response in neuron
Htr1A, Htr5A Gai
(96,97,98) Increase potassium GIRK/Kir3 currents Inhibition
Htr2A, Htr2C Gaq
(98) Decrease potassium currents
Increase nonselective cation current
Excitation
Htr4, Htr6 Gas
(98) Decrease potassium current
Increase nonselective cation current
Excitation
Information sourced from [96,97,98].
doi:10.1371/journal.pone.0022799.t002
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demographic correlate in our study with these six HTRs.
Discussion
We found large developmental changes in the expression of
several individual serotonin receptors in human prefrontal cortex.
While the mRNAs for two Gai-coupled inhibitory HTRs have a
relatively constant expression level across the life span, the mRNAs
encoding two excitatory Gaq-coupled and two Gas-coupled HTRs
increase to higher levels during childhood and teenage years
before declining to adult levels. However, some of these excitatory
HTRs may be expressed predominantly in inhibitory interneurons,
and thus may act to inhibit the prefrontal cortex. In support of this
hypothesis, we found significant relationships between the
developmental expression of certain HTRs and developmental
expression of specific interneuron markers. Overall, a collective
look at six prefrontal HTRs in terms of their neurophysiological
effects and cellular localization suggests the possibility that there
Table 3. Major and minor cortical cellular distribution of the
analyzed serotonin receptors.
Pyramidal neurons Interneurons
Htr1A*
(25, 26, 24, 27, 75) Htr1A
(27, 75)
Htr2A*
(25, 26, 24, 27, 75) Htr2A
(27,100, 99)
Htr4
(45, 21, 46) Htr2C
(26, 37, 35)
Htr5A
(26, 42, 41) Htr6
(48, 47)
*Htr1A and Htr2A are highly co-expressed in prefrontal pyramidal neurons (24,
27).
Bold font denotes predominant cellular localization in cerebral cortex. Italic font
denotes lesser cellular localization for receptors expressed in both excitatory
and inhibitory neurons. Information sourced from
[22,25,26,27,28,36,38,42,43,46,47,48,49,55,99,100].
doi:10.1371/journal.pone.0022799.t003
Figure 2. Developmental pattern of expression of Gaq-coupled serotonin receptors: HTR2A and HTR2C. (a) Normalized qPCR expression
for HTR2A in human prefrontal cortex across postnatal development. The expression of HTR2A changes significantly across the developmental groups
(F(6,53) =5.3, p,0.001) (b) Normalized qPCR expression for HTR2C in human prefrontal cortex across postnatal development. There is a significant
developmental change in HTR2C expression (F(6,52) =4.7, p=0.001). Asterisks show the significance levels of an ANOVA post-hoc Fisher LSD test
(*p,0.05,**p,0.01).
doi:10.1371/journal.pone.0022799.g002
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across human postnatal development. Developmental changes in
the expression of individual HTRs in the normal human prefrontal
cortex from infancy to adulthood give insight into how the brain
normally develops and provide a reference to compare changes
which may occur in response to genetic or environmental
circumstances which would alter one or more specific subtypes
of serotonin receptor.
Model for the developmental balance of the expression
of excitatory and inhibitory HTRs
We found strong developmental regulation of the individual HTR
mRNAs, in particular the Gaq-coupled and Gas-coupled HTRs.B y
considering the possible excitatory or inhibitory effect of our
measured HTRs, as well as their proposed cellular locations, we
produced the model illustrated in Figure 4. We calculated the
proposed interneuron contributions of the HTR receptors (HTR2A +
HTR2C + HTR6 – HTR1A)a sw e l la st h ep y r a m i d a lc e l lc o n t r i -
butions (HTR2A + HTR4 - HTR1A - HTR5A).By takingintoaccount
that excitation of inhibitory cells will result in an inhibition of
pyramidal cell firing, we were able to propose a net effect (dotted line
inFigure4) on the prefrontal cortex. This overalleffectwas seen to be
balanced throughout the course of prefrontal cortical development.
Overall, serotonin signalling may have an increased saliency in the
first 5–10 years of life since the expression of most HTR mRNAs
increase during this developmental period. In order to reduce the
complexity of the system, the model makes several assumptions. It
only includes 6 of the 14 known HTR receptors and does not take
into account variations in receptor densities and possible interactions
of second messenger systems. However, the model provides a useful
framework for evaluating the possible net effects of serotonin over the
course of prefrontal cortical development.
Developmental expression of Gai-coupled HTRs in
human prefrontal cortex
HTR1A: Perspective and clinical relevance. Our finding
of relatively constant HTR1A expression across human
development is consistent with the results of a previous
Figure 3. Developmental pattern of expression of Gas-coupled serotonin receptors: HTR4 and HTR6. (a) Normalized qPCR expression for
HTR4 in human prefrontal cortex across postnatal development. The expression of HTR4 changes significantly across the developmental groups
(F(6,50)=4.6, p=0.001). (b) Normalized qPCR expression for HTR6 in human prefrontal cortex across postnatal development. There is also a significant
developmental change in HTR6 expression (F(6,50)=4.9, p=0.001). Asterisks show the significance levels of an ANOVA post-hoc Fisher LSD test
(*p,0.05, **p,0.01).
doi:10.1371/journal.pone.0022799.g003
Developmental Changes in Human Prefrontal HTRs
PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22799developmental investigation in human postmortem tissue [57].
HTR1A has been a focus of myriad human postmortem and
imaging studies in adults. Work examining HTR1A binding in
prefrontal cortex suggests that such Gai-coupled receptors are
protective against anxiety in controls [32] and are reduced in
people with social anxiety [31]. Interestingly, there appears to be
an increase in HTR1A expression and binding in schizophrenia
[26,58,59,60].
The importance of maintaining constant expression of HTR1A
in prefrontal cortex during development should not be underes-
timated, since conditional loss of the forebrain Htr1A receptor
during development leads to life-long abnormal anxiety behaviour
[61,62]. Of note, HTR1A appears to be regulated by early life
experience in rodents and primates [41,63]. Human HTR1A is
highly expressed in superficial layers of prefrontal cortex [64].
Analysis of Htr1A expression and function in superficial prefrontal
cortex of rodent suggests that healthy animals have relatively
stable levels of this key inhibitory receptor [41]. However, a careful
examination of the in situ data [41], in the context of previous
neurophysiological examination [22,23], suggests that Htr1A may
have varying developmental mRNA expression patterns in the
superficial and deep cortical layers. An apparent lack of change in
HTR1A mRNA expression in the development of the prefrontal
cortex by qPCR analysis may obscure possible opposite develop-
mental changes in the superficial and deeper cortical layers
[22,41]. Despite a link to PV-containing interneurons [30,55,
56,65], HTR1A mRNA levels did not display a relationship
through regression with any mRNA marker of inhibitory neurons.
HTR5A: Perspective and clinical relevance. The other
Gai-coupled receptor we examined, HTR5A, is less fully
understood. We found its expression levels remain relatively
constant throughout development but it shows an unexpected and
fairly large increase in expression in adulthood. Stimulating
HTR5A may be underappreciated as a clinical target to protect the
brain under stressful conditions. A genetic deletion study in mouse
suggests that knocking out Htr5A produces abnormal behavioural
effects on stressful tests and inappropriate responses to novel
situations [45]. Interestingly, a close family member (Htr5B) has
recently been shown to be upregulated by the developmental stress
of social isolation after weaning [66].
Developmental expression of Gaq-coupled HTRs in
human prefrontal cortex
HTR2A: Perspective and clinical relevance. The HTR2A
receptor is the second most widely expressed serotonin receptor in
the prefrontal cortex after HTR1A and is also predominantly
expressed in pyramidal neurons [25,26,27,28,67]. In rodents, the
excitatory effects of cortical Htr2A are thought to promote anxiety
[33] and impulsivity [40]. In adult humans, HTR2A binding is
elevated in prefrontal cortex of subjects with mood disorders [35]
and also has been correlated with personality risk factors for
affective disorders, such as neuroticism [68,69]. HTR2A antagonism
contributes to the efficacy of medicines used to treat schizophrenia
to the extent that it may be a defining feature of the atypical
antipsychotic medicines [70]. However, it is controversial whether
there are changes in HTR2A expression or binding in schizophrenia
[26,59,71,72,73]. Yet, medicines that antagonize HTR2A improve
the symptoms of anxiety and depressive disorders in patients who
did not improve on other treatments [74,75,76,77]. In rodents,
geneticdeletion of cortical Htr2Adiminishedanxietylevels [33], and
pharmacological modulation of Htr2A within the prefrontal cortex
has bidirectional effects on impulsivity with stimulation increasing
and antagonism decreasing impulsivity [40]. Rodent work has also
Figure 4. Working model to illustrate the balanced developmental expression of HTRs with excitatory effects on prefrontal cortex
and those with inhibitory effects. The complex cellular localization of the HTRs and their different excitatory or inhibitory effects makes it difficult
to conceptualize how the developmental changes in their expression would affect the prefrontal cortex. Several assumptions were required in order
to formulate a working model that attempted to synthesize the potential consequences of these developmental changes. The mRNA expression of
each serotonin receptor was normalized to its individual peak expression which was given the value of one. Receptors on which serotonin has an
excitatory effect were assigned a positive contribution value while those receptors on which serotonin has an inhibitory effect were assigned a
negative value. The net HTR contribution to interneuron activity predicted by this model is plotted in black and was calculated as follows: (HTR2A +
HTR2C + HTR6 – HTR1A). The net HTR contribution to pyramidal neuron activity predicted by this model is plotted in gray and was calculated as
follows: (HTR2A + HTR4 - HTR1A - HTR5A). The overall effect of serotonin receptors on the output from the prefrontal cortex was based on the
predominant localization of each receptor. This net prefrontal effect is illustrated by the dashed line which takes into account that excitation on
inhibitory interneurons would likely result in inhibition of the firing of the pyramidal cells responsible for output. Note this working model suggests a
lack of a large developmental change in the predicted overall net effect of HTRs on the prefrontal cortex, despite an overall trend towards increased
expression of the excitatory serotonin receptors within the first decade of life. However, the 5HTR subtypes responsible for maintaining this balance
appear to change.
doi:10.1371/journal.pone.0022799.g004
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layers of cortex in the first two weeks of postnatal development
[22,23] and reduced effects in adulthood [78], likely due to the
competinginhibitoryeffectsofHtr1Awhichishighlyco-expressedin
cortical pyramidal neurons [25,28]. Recent work suggests that early
stress exposure may increase the functional effects of Htr2A in
adulthood with negligible changes in receptor expression, binding,
or sensitivity [78], suggesting potential elevation of downstream
signalling.
HTR2A mRNA also shows a remarkably strong positive
relationship with the interneuron markers PV and CB, both of
which show a protracted increase during the first decade of human
life [7]. Of note, the up-regulation of HTR2A, PV, and CB mRNA
mirrors the increase in gamma oscillation power which is found
during development [79]. PV and CB are found primarily in
inhibitory neurons which are electrophysiologically classified as
fast-spiking and which synapse onto the cell bodies of excitatory
neurons [80]. Htr2A has been suggested to modulate cortical
gamma oscillations [9,30] at least in part through its effects on fast
spiking interneurons [30,56].
HTR2C: Perspective and clinical relevance. HTR2C is
thought to have effects opposite to those of HTR2A within
prefrontal cortex. This difference may be due to the fact that
HTR2C is expressed in inhibitory interneurons [36,37,38] and not
in pyramidal neurons [46], while HTR2A is predominantly
expressed in pyramidal neurons with a minority of its expression
in interneurons [28]. Here, we show that the developmental
changes in HTR2C are linked to developmental changes in the
interneuronal marker, CCK. This relationship suggests that as
CCK interneurons mature they may increase HTR2C expression
and become more responsive to serotonin. Work in rodents
suggests that greater prefrontal HTR2C tone would act to decrease
impulsivity, since impulsivity is increased either by genetic deletion
of Htr2C [39] or by its pharmacological antagonism within
prefrontal cortex [40].
Developmental expression of Gas-coupled HTRs in
human prefrontal cortex
HTR4: Perspective and clinical relevance. The HTR4
receptor is found in prefrontal cortical pyramidal neurons
[24,46,47] and appears to have excitatory effects within
prefrontal cortex [22,24]. There is evidence that HTR4 agonists
improve cognitive functioning in rodent and primate models
[81,82]. Our findings are broadly consistent with rodent studies
suggesting that there is gradual up-regulation of this receptor
during development [83]. The surface expression and function of
HTR4 are thought to be regulated by the S100 family member p11
[84], which has been implicated in mood disorders and suicide
[85]. The HTR4 receptor gene also has a polymorphism which has
been linked to schizophrenia in a Japanese population [86].
HTR6: Perspective and clinical relevance. Htr6 appears to
be more strongly expressed in inhibitory interneurons [48,49] than in
pyramidal neurons [46]. We found that developmental changes in
HTR6 expression follow an inverted-U shaped pattern, with an initial
increase followed by a decrease. This expression profile mirrors that
for CB expression in our cohort, which corresponds to the proposed
interneuron localization of HTR6. Stimulation of this receptor has
been suggested to have anxiolytic [49,87] and anti-depressant effects
[88]. Yet HTR6 antagonism is an unusual feature of the atypical
antipsychotic clozapine [89]. Indeed, pharmacologically antagoni-
zing HTR6 acts to enhance cognition [51]. In our cohort, the
expression of HTR6 peaks at the toddler age group before decreasing
into adulthood, thus drugs acting on this receptor may produce
exaggerated effects if administered in childhood.
A balance seemingly tipped towards inhibition and
potential mechanisms of dysregulation
Quantification of the normalized expression of two serotonin
receptorslikelytohave netexcitatoryeffectsonthe prefrontalcortex
(HTR2A and HTR4) based on the available evidence, and four likely
to have net inhibitory effects (HTR1A, HTR2C, HTR5A, HTR6),
suggests that the effect of serotonin through these receptors may
remain balanced in the inhibitory range across development and in
adulthood. This prediction of a net inhibitory cortical response to
serotoninissupportedbyinvivostudiesofthecorticaleffectsofraphe
stimulation in adult rodents [11,25,29]. The overall effect of
serotonin on the cortex is complicated by the localization of a
number of these receptors on inhibitory interneurons (HTR2C,
HTR6, and to a lesser extent HTR1A, HTR2A). This is shown by the
widespread relationship between developmental changes in GA-
BAergic interneuron marker mRNA expression and those of HTRs
expression. In particular, there is a statistical relationship demon-
strated through linear regression for HTR2A and HTR6 mRNA
with the interneuron marker CB, in addition to a relationship
between HTR2C, and the interneuron marker CCK.
The hypothesized balance between excitation and inhibition
for this group of receptors may be disrupted during development
when the expression or function of individual HTRs are changed
by polymorphisms, early life stress, or developmental exposure to
serotonergic medicines. For example, the developmental trajec-
tory of HTR2A suggests that the period of increased HTR2A
mRNA expression from childhood through the teenage years
may be a time when the brain would be particularly vulnerable to
increased developmental Htr2A expression resulting from early
maternal deprivation [78,90]. If unchecked by the highly co-
expressed inhibitory Htr1A [25,28], or by the excitatory Htr2C
expressed in inhibitory neurons [35,36,37,38,39], such changes
would be hypothesized to lead to greater impulsivity [39,40]
particularly under stressful conditions which would increase
serotonin release [1,11,91]. Changes to the expression or function
of HTRs have been shown to occur as a result of genetic
polymorphisms [92,93,94], early life experience [41], and
developmental pharmaceutical exposure [15,95]. Disrupting a
normal balance in the effects of serotonin on the prefrontal cortex
during a vulnerable developmental period may result in
abnormal emotional regulation, cognition, and behaviour in the
short term. Furthermore, the trophic effects of serotonin on
maturing neurons [18,19,20,21], suggests that dysregulation of an
individual HTR may have lasting repercussions for adult
prefrontal cortical structure and function.
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